Tim Meyer
The Royal Free Hospital(GB)Cancer Research UK(GB)Ghent University(BE)London Cancer(GB)Vivantes Klinikum(DE)CRUK Lung Cancer Centre of Excellence(GB)University College London(GB)Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Pancreatic and Hepatic Oncology Research, Neuroblastoma Research and Treatments
Most-Cited Works
- → Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial(2017)4,261 cited
- → Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma(2018)2,297 cited
- → Hepatocellular carcinoma(2022)2,124 cited
- → Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial(2017)1,902 cited
- → Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma(2020)1,150 cited
- → Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2018)1,047 cited